This is a prospective observational cohort study (AI-Kidney-Prognosis), aiming to non-invasively predict the clinical outcomes in renal cell carcinoma patients after surgical treatment using radiomics-based AI models, thereby assisting clinical decision-making and personalized follow-up strategies.
Study Type
OBSERVATIONAL
Enrollment
400
Union Hospital,Tongji Medical College,Huazhong University of Science and Technology
Wuhan, Hubei, China
Progression-free survival
Time frame: 1 year
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.